Managing early breast cancer: Prognostic features guide choice of therapy

Hamid R. Mirshahidi; Jame Abraham

doi:10.3810/pgm.2004.10.1596

Managing early breast cancer: Prognostic features guide choice of therapy

Hamid R. Mirshahidi
, Jame Abraham

Research output: Contribution to journal › Article › peer-review

Abstract

In the United States, more than 90% of breast cancer diagnoses occur in an early stage of the disease. That so much detection happens early bodes well for the patient. However, it is only one part of the clinical picture. Various features, such as lymph node involvement and receptor status, help predict outcome, aid in treatment selection, and are crucial factors in survival. Here, the authors present the current considerations and treatment guidelines for early-stage breast cancer. © 2004, Taylor and Francis Group, LLC. All rights reserved.

Original language	English
Pages (from-to)	23-34
Number of pages	12
Journal	Postgraduate Medicine
Volume	116
Issue number	4
DOIs	https://doi.org/10.3810/pgm.2004.10.1596
State	Published - Oct 1 2004
Externally published	Yes

ASJC Scopus Subject Areas

General Medicine

Keywords

Antineoplastic Combined Chemotherapy Protocols/therapeutic use
Aromatase Inhibitors
Mastectomy/methods
Prognosis
Breast Neoplasms/pathology
Sentinel Lymph Node Biopsy/methods
Humans
Tamoxifen/therapeutic use
Female
Neoplasm Staging
Radiotherapy/methods

Access to Document

10.3810/pgm.2004.10.1596License: Unspecified

OpenUrl availability

Full text

Cite this

@article{e4fdbd63a9374008a992ace32f440d8e,

title = "Managing early breast cancer: Prognostic features guide choice of therapy",

abstract = "In the United States, more than 90\% of breast cancer diagnoses occur in an early stage of the disease. That so much detection happens early bodes well for the patient. However, it is only one part of the clinical picture. Various features, such as lymph node involvement and receptor status, help predict outcome, aid in treatment selection, and are crucial factors in survival. Here, the authors present the current considerations and treatment guidelines for early-stage breast cancer. {\textcopyright} 2004, Taylor and Francis Group, LLC. All rights reserved.",

keywords = "Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Aromatase Inhibitors, Mastectomy/methods, Prognosis, Breast Neoplasms/pathology, Sentinel Lymph Node Biopsy/methods, Humans, Tamoxifen/therapeutic use, Female, Neoplasm Staging, Radiotherapy/methods",

author = "Mirshahidi, \{Hamid R.\} and Jame Abraham",

note = "Postgrad Med. 2004 Oct;116(4):23-6, 32-4. Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Review",

year = "2004",

month = oct,

day = "1",

doi = "10.3810/pgm.2004.10.1596",

language = "English",

volume = "116",

pages = "23--34",

journal = "Postgraduate Medicine",

issn = "0032-5481",

number = "4",

}

TY - JOUR

T1 - Managing early breast cancer

T2 - Prognostic features guide choice of therapy

AU - Mirshahidi, Hamid R.

AU - Abraham, Jame

N1 - Postgrad Med. 2004 Oct;116(4):23-6, 32-4. Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Review

PY - 2004/10/1

Y1 - 2004/10/1

N2 - In the United States, more than 90% of breast cancer diagnoses occur in an early stage of the disease. That so much detection happens early bodes well for the patient. However, it is only one part of the clinical picture. Various features, such as lymph node involvement and receptor status, help predict outcome, aid in treatment selection, and are crucial factors in survival. Here, the authors present the current considerations and treatment guidelines for early-stage breast cancer. © 2004, Taylor and Francis Group, LLC. All rights reserved.

AB - In the United States, more than 90% of breast cancer diagnoses occur in an early stage of the disease. That so much detection happens early bodes well for the patient. However, it is only one part of the clinical picture. Various features, such as lymph node involvement and receptor status, help predict outcome, aid in treatment selection, and are crucial factors in survival. Here, the authors present the current considerations and treatment guidelines for early-stage breast cancer. © 2004, Taylor and Francis Group, LLC. All rights reserved.

KW - Antineoplastic Combined Chemotherapy Protocols/therapeutic use

KW - Aromatase Inhibitors

KW - Mastectomy/methods

KW - Prognosis

KW - Breast Neoplasms/pathology

KW - Sentinel Lymph Node Biopsy/methods

KW - Humans

KW - Tamoxifen/therapeutic use

KW - Female

KW - Neoplasm Staging

KW - Radiotherapy/methods

UR - https://www.scopus.com/pages/publications/19644398046

UR - https://www.scopus.com/pages/publications/19644398046#tab=citedBy

UR - https://www.mendeley.com/catalogue/feae4623-c902-3f74-b369-91b97db1ba6d/

U2 - 10.3810/pgm.2004.10.1596

DO - 10.3810/pgm.2004.10.1596

M3 - Article

C2 - 15510591

SN - 0032-5481

VL - 116

SP - 23

EP - 34

JO - Postgraduate Medicine

JF - Postgraduate Medicine

IS - 4

ER -

Managing early breast cancer: Prognostic features guide choice of therapy

Abstract

ASJC Scopus Subject Areas

Keywords

Access to Document

OpenUrl availability

Other files and links

Cite this